InMed Pharmaceuticals Inc. (INM) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- InMed Pharmaceuticals Inc. INM 1.32 −0.75%
- Sonoma Pharmaceuticals, Inc. SNOA 1.13 −1.74%
InMed Pharmaceuticals Inc. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $5.5M — 1.3× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against 19.4%. InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 16 metrics below, Sonoma Pharmaceuticals, Inc. leads on 10 and InMed Pharmaceuticals Inc. on 6.
Valuation
Profitability
| Metric | INM | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 26.27% | 38.91% | 53.94% |
| Operating margin | 0.00% | (6.41%) | 0.00% |
| Net margin | 0.00% | (10.33%) | 0.00% |
| Free cash flow margin | 0.00% | (12.11%) | 0.00% |
| Return on equity | (179.09%) | (42.52%) | (0.40%) |
| Return on assets | (139.63%) | (13.85%) | (3.32%) |
| Return on invested capital | 0.00% | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack